Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

Giuseppe Montalto; Manfredi Rizzo; Angelo Maria Patti; Manisha Chandalia; Nicola Abate; Ali A. Rizvi; Manfredi Rizzo

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

Giuseppe Montalto, Manfredi Rizzo, Angelo Maria Patti, Manisha Chandalia, Nicola Abate, Ali A. Rizvi, Manfredi Rizzo

Risultato della ricerca: Article › peer review

Abstract

BACKGROUND: Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. METHODS: A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of coronary artery disease evaluated whether adding liraglutide to metformin affects carotid IMT, measured by color doppler ultrasound. RESULTS: After 8 months, fasting glucose decreased by 2.1 mmol/l and HbA1c by 1.9% (p

Lingua originale	English
pagine (da-a)	49-
Numero di pagine	5
Rivista	Cardiovascular Diabetology
Volume	13
Stato di pubblicazione	Published - 2014

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2712???
???subjectarea.asjc.2700.2705???

Altri file e collegamenti

Cita questo

@article{2ac10b4fc99448b49b5b9bcc66616630,

title = "Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.",

abstract = "BACKGROUND: Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. METHODS: A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of coronary artery disease evaluated whether adding liraglutide to metformin affects carotid IMT, measured by color doppler ultrasound. RESULTS: After 8 months, fasting glucose decreased by 2.1 mmol/l and HbA1c by 1.9% (p ",

author = "Giuseppe Montalto and Manfredi Rizzo and Patti, {Angelo Maria} and Manisha Chandalia and Nicola Abate and Rizvi, {Ali A.} and Manfredi Rizzo",

year = "2014",

language = "English",

volume = "13",

pages = "49--",

journal = "Cardiovascular Diabetology",

issn = "1475-2840",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

AU - Montalto, Giuseppe

AU - Rizzo, Manfredi

AU - Patti, Angelo Maria

AU - Chandalia, Manisha

AU - Abate, Nicola

AU - Rizvi, Ali A.

AU - Rizzo, Manfredi

PY - 2014

Y1 - 2014

N2 - BACKGROUND: Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. METHODS: A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of coronary artery disease evaluated whether adding liraglutide to metformin affects carotid IMT, measured by color doppler ultrasound. RESULTS: After 8 months, fasting glucose decreased by 2.1 mmol/l and HbA1c by 1.9% (p

AB - BACKGROUND: Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. METHODS: A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of coronary artery disease evaluated whether adding liraglutide to metformin affects carotid IMT, measured by color doppler ultrasound. RESULTS: After 8 months, fasting glucose decreased by 2.1 mmol/l and HbA1c by 1.9% (p

UR - http://hdl.handle.net/10447/132752

UR - http://www.ncbi.nlm.nih.gov/pubmed/24559258

M3 - Article

SN - 1475-2840

VL - 13

SP - 49-

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

ER -

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo